Search

Search Constraints

You searched for: Author/Creator Loarec, Anne

Search Results

1. An intensive model of care for hepatitis C virus screening and treatment with direct‐acting antivirals in people who inject drugs in Nairobi, Kenya: a model‐based cost‐effectiveness analysis. (28th July 2021)

2. Cost and cost-effectiveness of a real-world HCV treatment program among HIV-infected individuals in Myanmar. Issue 2 (24th February 2021)

3. Cost and cost‐effectiveness of a simplified treatment model with direct‐acting antivirals for chronic hepatitis C in Cambodia. (21st June 2020)

4. Cost‐effectiveness of screening and treatment using direct‐acting antivirals for chronic Hepatitis C virus in a primary care setting in Karachi, Pakistan. Issue 2 (4th November 2020)

5. Determining the lower limit of detection required for HCV viral load assay for test of cure following direct‐acting antiviral‐based treatment regimens: Evidence from a global data set. Issue 6 (30th March 2022)

6. Effects and cost of different strategies to eliminate hepatitis C virus transmission in Pakistan: a modelling analysis. Issue 3 (March 2020)

7. Epidemiological characteristics and real‐world treatment outcomes of hepatitis C among HIV/HCV co‐infected patients in Myanmar: A prospective cohort study. Issue 2 (17th February 2023)

8. Extremely low hepatitis C prevalence among HIV co-infected individuals in four countries in sub-Saharan Africa. (1st February 2019)

9. Field evaluation of GeneXpert® (Cepheid) HCV performance for RNA quantification in a genotype 1 and 6 predominant patient population in Cambodia. Issue 1 (3rd December 2018)

10. Hepatitis C treatment program in Maputo, Mozambique, the challenge of genotypes and key populations: A 5‐year retrospective analysis of routine programmatic data. Issue 4 (30th March 2023)